iomeprol has been researched along with Histiocytosis, Sinus in 1 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
Histiocytosis, Sinus: Benign, non-Langerhans-cell, histiocytic proliferative disorder that primarily affects the lymph nodes. It is often referred to as sinus histiocytosis with massive lymphadenopathy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Varrassi, M | 1 |
| Corridore, A | 1 |
| Tommasino, E | 1 |
| Saltelli, G | 1 |
| Bruno, F | 1 |
| Di Sibio, A | 1 |
| Splendiani, A | 1 |
| Di Cesare, E | 1 |
| Masciocchi, C | 1 |
1 review available for iomeprol and Histiocytosis, Sinus
| Article | Year |
|---|---|
MR imaging of cerebral involvement of Rosai-Dorfman disease: a single-centre experience with review of the literature.
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Histiocytosis, Sinus; Humans; Imaging, Three-D | 2021 |